Cargando…
Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers
BACKGROUND: Central to the design of a randomised controlled trial is the calculation of the number of participants needed. This is typically achieved by specifying a target difference and calculating the corresponding sample size, which provides reassurance that the trial will have the required sta...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302137/ https://www.ncbi.nlm.nih.gov/pubmed/25928502 http://dx.doi.org/10.1186/s13063-014-0526-8 |
_version_ | 1782353745327161344 |
---|---|
author | Cook, Jonathan A Hislop, Jenni Altman, Douglas G Fayers, Peter Briggs, Andrew H Ramsay, Craig R Norrie, John D Harvey, Ian M Buckley, Brian Fergusson, Dean Ford, Ian Vale, Luke D |
author_facet | Cook, Jonathan A Hislop, Jenni Altman, Douglas G Fayers, Peter Briggs, Andrew H Ramsay, Craig R Norrie, John D Harvey, Ian M Buckley, Brian Fergusson, Dean Ford, Ian Vale, Luke D |
author_sort | Cook, Jonathan A |
collection | PubMed |
description | BACKGROUND: Central to the design of a randomised controlled trial is the calculation of the number of participants needed. This is typically achieved by specifying a target difference and calculating the corresponding sample size, which provides reassurance that the trial will have the required statistical power (at the planned statistical significance level) to identify whether a difference of a particular magnitude exists. Beyond pure statistical or scientific concerns, it is ethically imperative that an appropriate number of participants should be recruited. Despite the critical role of the target difference for the primary outcome in the design of randomised controlled trials, its determination has received surprisingly little attention. This article provides guidance on the specification of the target difference for the primary outcome in a sample size calculation for a two parallel group randomised controlled trial with a superiority question. METHODS: This work was part of the DELTA (Difference ELicitation in TriAls) project. Draft guidance was developed by the project steering and advisory groups utilising the results of the systematic review and surveys. Findings were circulated and presented to members of the combined group at a face-to-face meeting, along with a proposed outline of the guidance document structure, containing recommendations and reporting items for a trial protocol and report. The guidance and was subsequently drafted and circulated for further comment before finalisation. RESULTS: Guidance on specification of a target difference in the primary outcome for a two group parallel randomised controlled trial was produced. Additionally, a list of reporting items for protocols and trial reports was generated. CONCLUSIONS: Specification of the target difference for the primary outcome is a key component of a randomized controlled trial sample size calculation. There is a need for better justification of the target difference and reporting of its specification. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-014-0526-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4302137 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43021372015-01-23 Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers Cook, Jonathan A Hislop, Jenni Altman, Douglas G Fayers, Peter Briggs, Andrew H Ramsay, Craig R Norrie, John D Harvey, Ian M Buckley, Brian Fergusson, Dean Ford, Ian Vale, Luke D Trials Research BACKGROUND: Central to the design of a randomised controlled trial is the calculation of the number of participants needed. This is typically achieved by specifying a target difference and calculating the corresponding sample size, which provides reassurance that the trial will have the required statistical power (at the planned statistical significance level) to identify whether a difference of a particular magnitude exists. Beyond pure statistical or scientific concerns, it is ethically imperative that an appropriate number of participants should be recruited. Despite the critical role of the target difference for the primary outcome in the design of randomised controlled trials, its determination has received surprisingly little attention. This article provides guidance on the specification of the target difference for the primary outcome in a sample size calculation for a two parallel group randomised controlled trial with a superiority question. METHODS: This work was part of the DELTA (Difference ELicitation in TriAls) project. Draft guidance was developed by the project steering and advisory groups utilising the results of the systematic review and surveys. Findings were circulated and presented to members of the combined group at a face-to-face meeting, along with a proposed outline of the guidance document structure, containing recommendations and reporting items for a trial protocol and report. The guidance and was subsequently drafted and circulated for further comment before finalisation. RESULTS: Guidance on specification of a target difference in the primary outcome for a two group parallel randomised controlled trial was produced. Additionally, a list of reporting items for protocols and trial reports was generated. CONCLUSIONS: Specification of the target difference for the primary outcome is a key component of a randomized controlled trial sample size calculation. There is a need for better justification of the target difference and reporting of its specification. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-014-0526-8) contains supplementary material, which is available to authorized users. BioMed Central 2015-01-15 /pmc/articles/PMC4302137/ /pubmed/25928502 http://dx.doi.org/10.1186/s13063-014-0526-8 Text en © Cook et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Cook, Jonathan A Hislop, Jenni Altman, Douglas G Fayers, Peter Briggs, Andrew H Ramsay, Craig R Norrie, John D Harvey, Ian M Buckley, Brian Fergusson, Dean Ford, Ian Vale, Luke D Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers |
title | Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers |
title_full | Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers |
title_fullStr | Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers |
title_full_unstemmed | Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers |
title_short | Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers |
title_sort | specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302137/ https://www.ncbi.nlm.nih.gov/pubmed/25928502 http://dx.doi.org/10.1186/s13063-014-0526-8 |
work_keys_str_mv | AT cookjonathana specifyingthetargetdifferenceintheprimaryoutcomeforarandomisedcontrolledtrialguidanceforresearchers AT hislopjenni specifyingthetargetdifferenceintheprimaryoutcomeforarandomisedcontrolledtrialguidanceforresearchers AT altmandouglasg specifyingthetargetdifferenceintheprimaryoutcomeforarandomisedcontrolledtrialguidanceforresearchers AT fayerspeter specifyingthetargetdifferenceintheprimaryoutcomeforarandomisedcontrolledtrialguidanceforresearchers AT briggsandrewh specifyingthetargetdifferenceintheprimaryoutcomeforarandomisedcontrolledtrialguidanceforresearchers AT ramsaycraigr specifyingthetargetdifferenceintheprimaryoutcomeforarandomisedcontrolledtrialguidanceforresearchers AT norriejohnd specifyingthetargetdifferenceintheprimaryoutcomeforarandomisedcontrolledtrialguidanceforresearchers AT harveyianm specifyingthetargetdifferenceintheprimaryoutcomeforarandomisedcontrolledtrialguidanceforresearchers AT buckleybrian specifyingthetargetdifferenceintheprimaryoutcomeforarandomisedcontrolledtrialguidanceforresearchers AT fergussondean specifyingthetargetdifferenceintheprimaryoutcomeforarandomisedcontrolledtrialguidanceforresearchers AT fordian specifyingthetargetdifferenceintheprimaryoutcomeforarandomisedcontrolledtrialguidanceforresearchers AT valeluked specifyingthetargetdifferenceintheprimaryoutcomeforarandomisedcontrolledtrialguidanceforresearchers AT specifyingthetargetdifferenceintheprimaryoutcomeforarandomisedcontrolledtrialguidanceforresearchers |